eMedicine Specialties > Dermatology > Reactive & Inflammatory Dermatoses

Balanitis Circumscripta Plasmacellularis

Author: Noah S Scheinfeld, MD, JD, FAAD, Assistant Clinical Professor, Department of Dermatology, Columbia University; Consulting Staff, Department of Dermatology, St Luke's Roosevelt Hospital Center, Beth Israel Medical Center, New York Eye and Ear Infirmary; Private Practice
Coauthor(s): George C Keough, MD, Chief, Clinical Assistant Professor, Department of Medicine, Dermatology Service, Eisenhower Army Medical Center; Daniel S Lehman, MD, Fellow in Minimally Invasive Urology/Oncology, Department of Urology, Columbia University Medical Center
Contributor Information and Disclosures

Updated: Mar 17, 2008

Introduction

Background

In 1952, J.J. Zoon1 first recognized balanitis circumscripta plasmacellularis or plasma cell balanitis (PCB) is an idiopathic, rare, benign penile dermatosis. It is important to distinguish this benign condition from the clinically similar neoplastic erythroplasia of Queyrat.

Immunohistologically, immunoglobulin E and immunoglobulin G are found to be major immunoglobulin classes in the plasma cellular infiltrate. Immunoglobulin M–positive cells are either absent or present in very low numbers. Although a specific allergen has not been identified, the findings suggest that this condition could be related to immediate hypersensitivity.

The kappa-to-lambda ratio is variable. This suggests a nonspecific polyclonal stimulation of B cells in the basis of PCB, which might be caused by a persistent infection.

Other related eMedicine articles include Bowen Disease, Lichen Sclerosus et Atrophicus, Erythroplasia of Queyrat (Bowen Disease of the Glans Penis), Balanitis Xerotica Obliterans, and Balanitis. In addition, the Medscape CME course HPV-Related Disease in Men: Anal and Penile Cancer (Slides With Transcript) may be helpful.

Frequency

International

Mallon et al2 studied 357 male referral patients with genital skin disease. They studied a control group of 305 male dermatology clinic patients without genital skin disease over a 120-day period. Their goal was to investigate the relationship between circumcision and penile disease. Mallon et al2 compiled the percentage of circumcision in the general male dermatology population. Zoon balanitis occurred in 27 patients. More patients had squamous cell carcinoma, bowenoid papulosis, and Bowen disease. They noted that every patient with Zoon balanitis, bowenoid papulosis, and nonspecific balanoposthitis had not been circumcised.

Sex

PCB affects males. Analogous lesions sharing both clinical and histologic features of PCB have been reported in women as vulvitis circumscripta plasmacellularis.

Age

PCB is most common in middle-aged to older men, with cases reported in patients aged 20-88 years.

Clinical

History

The patient, a male of middle age or older, usually presents with a characteristic lesion of the glans penis or prepuce, present for an average of 1-2 years before diagnosis. Symptoms are minimal, but patients may complain of mild pruritus or tenderness. Some patients present for evaluation because of cosmetic concerns or anxiety. Bloodstaining of the underclothes for 5 months prior to presentation has been reported in a patient with PCB. In 2007, Toker et al3 reported on Zoon balanitis in a circumcised man.

Physical

The PCB lesion is usually a solitary, glistening, shiny, red-to-orange plaque of the glans or prepuce of an uncircumcised male. The lesions may exhibit a yellowish hue with pinpoint purpuric "cayenne pepper" spotting. Erosive and vegetative variants have been reported. Bowen disease of the glans penis (erythroplasia of Queyrat) has been reported in association with PCB; thus, attention must be given to possible neoplastic associations with this condition.

Kumar et al4 studied 112 persons with a clinical diagnosis of PCB ranging in age from 24-70 years. Most had been symptomatic for more than 12 months. Plaques manifested on the prepuce and glans in 58.92% of patients, in the prepuce only in 23.21% of patients, and on the glans only in 17.85% patients.

Causes

The etiology of PCB is unknown. Importantly, all confirmed cases have been in uncircumcised males. It has been proposed that friction, trauma, heat, poor hygiene, chronic infection with Mycobacterium smegmatis, a reactive response to an unknown exogenous or infectious agent, an immediate hypersensitivity response mediated by immunoglobulin E class antibodies, and hypospadias may be predisposing or inciting agents. There is no evidence of human papilloma virus infection in PCB.

More on Balanitis Circumscripta Plasmacellularis

Overview: Balanitis Circumscripta Plasmacellularis
Differential Diagnoses & Workup: Balanitis Circumscripta Plasmacellularis
Treatment & Medication: Balanitis Circumscripta Plasmacellularis
Follow-up: Balanitis Circumscripta Plasmacellularis
References
[ CLOSE WINDOW ]

References

  1. Zoon JJ. [Chronic benign circumscript plasmocytic balanoposthitis.]. Dermatologica. 1952;105(1):1-7. [Medline].

  2. Mallon E, Hawkins D, Dinneen M, Francics N, Fearfield L, Newson R, et al. Circumcision and genital dermatoses. Arch Dermatol. Mar 2000;136(3):350-4. [Medline].

  3. Toker SC, Baskan EB, Tunali S, Yilmaz M, Karadogan SK. Zoon's balanitis in a circumcised man. J Am Acad Dermatol. Aug 2007;57(2 Suppl):S6-7. [Medline].

  4. Kumar B, Narang T, Dass Radotra B, Gupta S. Plasma cell balanitis: clinicopathologic study of 112 cases and treatment modalities. J Cutan Med Surg. Jan-Feb 2006;10(1):11-5. [Medline].

  5. Babu CS, Vitharana S, Higgins SP. Primary syphilis presenting as balanitis. Int J STD AIDS. Jul 2007;18(7):497-8. [Medline].

  6. Alessi E, Coggi A, Gianotti R. Review of 120 biopsies performed on the balanopreputial sac. from zoon's balanitisto the concept of a wider spectrum of inflammatory non-cicatricial balanoposthitis. Dermatology. 2004;208(2):120-4. [Medline].

  7. Weyers W, Ende Y, Schalla W, Diaz-Cascajo C. Balanitis of Zoon: a clinicopathologic study of 45 cases. Am J Dermatopathol. Dec 2002;24(6):459-67. [Medline].

  8. Hernandez-Machin B, Hernando LB, Marrero OB, Hernandez B. Plasma cell balanitis of Zoon treated successfully with topical tacrolimus. Clin Exp Dermatol. Sep 2005;30(5):588-9.

  9. Roé E, Dalmau J, Peramiquel L, Pérez M, López-Lozano HE, Alomar A. Plasma cell balanitis of zoon treated with topical tacrolimus 0.1%: report of three cases. J Eur Acad Dermatol Venereol. Feb 2007;21(2):284-5. [Medline].

  10. Moreno-Arias GA, Camps-Fresneda A, Llaberia C, Palou-Almerich J. Plasma cell balanitis treated with tacrolimus 0.1%. Br J Dermatol. Dec 2005;153(6):1204-6. [Medline].

  11. Virgili A, Mantovani L, Lauriola MM, Marzola A, Corazza M. Tacrolimus 0.1% Ointment: Is It Really Effective in Plasma Cell Vulvitis?. Report of Four Cases. Dermatology. Jan 9 2008;216(3):243-6. [Medline].

  12. Bardazzi F, Antonucci A, Savoia F, Balestri R. Two cases of Zoon's balanitis treated with pimecrolimus 1% cream. Int J Dermatol. Feb 2008;47(2):198-201. [Medline].

  13. Nasca MR, De Pasquale R, Micali G. Treatment of Zoon's balanitis with imiquimod 5% cream. J Drugs Dermatol. May 2007;6(5):532-4. [Medline].

  14. Petersen CS, Thomsen K. Fusidic acid cream in the treatment of plasma cell balanitis. J Am Acad Dermatol. Oct 1992;27(4):633-4. [Medline].

  15. Morioka S, Nakajima S, Yaguchi H, Naito K, Iwahara K, Ogawa H. Vulvitis circumscripta plasmacellularis treated successfully with interferon alpha. J Am Acad Dermatol. Nov 1988;19(5 Pt 2):947-50. [Medline].

  16. Ferrandiz C, Ribera M. Zoon's balanitis treated by circumcision. J Dermatol Surg Oncol. Aug 1984;10(8):622-5. [Medline].

  17. Kumar B, Sharma R, Rajagopalan M, Radotra BD. Plasma cell balanitis: clinical and histopathological features-- response to circumcision. Genitourin Med. Feb 1995;71(1):32-4. [Medline].

  18. Sonnex TS, Dawber RP, Ryan TJ, Ralfs IG. Zoon's (plasma-cell) balanitis: treatment by circumcision. Br J Dermatol. May 1982;106(5):585-8. [Medline].

  19. Baldwin HE, Geronemus RG. The treatment of Zoon's balanitis with the carbon dioxide laser. J Dermatol Surg Oncol. May 1989;15(5):491-4. [Medline].

  20. Retamar RA, Kien MC, Chouela EN. Zoon's balanitis: presentation of 15 patients, five treated with a carbon dioxidelaser. Int J Dermatol. Apr 2003;42(4):305-7. [Medline].

  21. Palminteri E, Berdondini E, Lazzeri M, Mirri F, Barbagli G. Resurfacing and reconstruction of the glans penis. Eur Urol. Sep 2007;52(3):893-8. [Medline].

  22. Davis DA, Cohen PR. Balanitis circumscripta plasmacellularis. J Urol. Feb 1995;153(2):424-6. [Medline].

  23. Davis-Daneshfar A, Trueb RM. Bowen's disease of the glans penis (erythroplasia of Queyrat) in plasma cell balanitis. Cutis. 2000;65:395-8. [Medline].

  24. English JC 3rd, Laws RA, Keough GC, Wilde JL, Foley JP, Elston DM. Dermatoses of the glans penis and prepuce. J Am Acad Dermatol. Jul 1997;37(1):1-24; quiz 25-6. [Medline].

  25. Erdogan BS, Demirkan N, Aktan S, Ergin S, Evliyaoglu D. A focus on differential diagnosis of lichen planus and plasma cell balanitis. J Eur Acad Dermatol Venereol. Jul 2006;20(6):746-8. [Medline].

  26. Houser ER, Gaston KE, Funkhouser WK, Israel B, Lavelle JP. Plasma cell (Zoon's) balanitis with concomitant HIV infection. Urology. Sep 2005;66(3):657. [Medline].

  27. Jolly BB, Krishnamurty S, Vaidyanathan S. Zoon's balanitis. Urol Int. 1993;50(3):182-4. [Medline].

  28. Kiene P, Folster-Holst R. No evidence of human papillomavirus infection in balanitis circumscripta plasmacellularis Zoon. Acta Derm Venereol. Nov 1995;75(6):496-7. [Medline].

  29. Kossard S, Shumack S. Lichen aureus of the glans penis as an expression of Zoon's balanitis. J Am Acad Dermatol. Oct 1989;21(4 Pt 1):804-6. [Medline].

  30. Murray WJ, Fletcher MS, Yates-Bell AJ, Pryor JP, Darby AJ, Packham DA. Plasma cell balinitis of Zoon. Br J Urol. Dec 1986;58(6):689-91. [Medline].

  31. Nishimura M, Matsuda T, Muto M, Hori Y. Balanitis of Zoon. Int J Dermatol. Jul-Aug 1990;29(6):421-3. [Medline].

  32. Ohta K, Horiguchi Y. Case of balanitis circumscripta plasmacellularis. J Dermatol. 2007 Apr;34(4):273-4. [Medline].

  33. Pastar Z, Rados J, Lipozencic J, Skerlev M, Loncaric D. Zoon plasma cell balanitis: an overview and role of histopathology. Acta Dermatovenerol Croat. 2004;12(4):268-73. [Medline].

  34. Souteyrand P, Wong E, MacDonald DM. Zoon's balanitis (balanitis circumscripta plasmacellularis). Br J Dermatol. Aug 1981;105(2):195-9. [Medline].

  35. Stern JK, Rosen T. Balanitis plasmacellularis circumscripta (Zoon's balanitis plasmacellularis). Cutis. Jan 1980;25(1):57-60. [Medline].

  36. Toonstra J, van Wichen DF. Immunohistochemical characterization of plasma cells in Zoon's balanoposthitis and (pre)malignant skin lesions. Dermatologica. 1986;172(2):77-81. [Medline].

  37. White JW Jr, Olsen KD, Banks PM. Plasma cell orificial mucositis. Report of a case and review of the literature. Arch Dermatol. Nov 1986;122(11):1321-4. [Medline].

  38. Yoganathan S, Bohl TG, Mason G. Plasma cell balanitis and vulvitis (of Zoon). A study of 10 cases. J Reprod Med. Dec 1994;39(12):939-44. [Medline].

[ CLOSE WINDOW ]

Further Reading

[ CLOSE WINDOW ]

Keywords

plasma cell balanitis, Zoon balanitis,  plasma cell mucositis

[ CLOSE WINDOW ]

Contributor Information and Disclosures

Author

Noah S Scheinfeld, MD, JD, FAAD, Assistant Clinical Professor, Department of Dermatology, Columbia University; Consulting Staff, Department of Dermatology, St Luke's Roosevelt Hospital Center, Beth Israel Medical Center, New York Eye and Ear Infirmary; Private Practice
Noah S Scheinfeld, MD, JD, FAAD is a member of the following medical societies: American Academy of Dermatology
Disclosure: Optigenex Consulting fee Independent contractor

Coauthor(s)

George C Keough, MD, Chief, Clinical Assistant Professor, Department of Medicine, Dermatology Service, Eisenhower Army Medical Center
George C Keough, MD is a member of the following medical societies: American Academy of Dermatology and American Medical Association
Disclosure: Nothing to disclose.

Daniel S Lehman, MD, Fellow in Minimally Invasive Urology/Oncology, Department of Urology, Columbia University Medical Center
Disclosure: Nothing to disclose.

Medical Editor

Janet Fairley, MD, Professor, Program Director, Section Chief, Department of Dermatology, Medical College of Wisconsin
Janet Fairley, MD is a member of the following medical societies: American Academy of Dermatology, American Dermatological Association, American Federation for Medical Research, and Society for Investigative Dermatology
Disclosure: Nothing to disclose.

Pharmacy Editor

Richard P Vinson, MD, Assistant Clinical Professor, Department of Dermatology, Texas Tech University School of Medicine; Consulting Staff, Mountain View Dermatology, PA
Richard P Vinson, MD is a member of the following medical societies: American Academy of Dermatology, Association of Military Dermatologists, Texas Dermatological Society, and Texas Medical Association
Disclosure: Nothing to disclose.

Managing Editor

Rosalie Elenitsas, MD, Associate Professor of Dermatology, University of Pennsylvania School of Medicine; Director, Penn Cutaneous Pathology Services, Department of Dermatology, University of Pennsylvania Health System
Rosalie Elenitsas, MD is a member of the following medical societies: American Society of Dermatopathology
Disclosure: Nothing to disclose.

CME Editor

Catherine Quirk, MD, Clinical Assistant Professor, Department of Dermatology, Brown University
Catherine Quirk, MD is a member of the following medical societies: Alpha Omega Alpha and American Academy of Dermatology
Disclosure: Nothing to disclose.

Chief Editor

Dirk M Elston, MD, Director, Department of Dermatology, Geisinger Medical Center
Dirk M Elston, MD is a member of the following medical societies: American Academy of Dermatology
Disclosure: Nothing to disclose.

 
 
HONcode

We subscribe to the
HONcode principles of the
Health On the Net Foundation

All material on this website is protected by copyright, Copyright© 1994- by Medscape.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.